Page 337 - 2022_01-Haematologica-web

Letters to the Editor
factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med.
2021;384(23):2202-2211.
3. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic throm-
bocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med.
2021;384(22):2092-2101.
4.Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and
thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J
Med. 2021;384(22):2124-2130.
5.Cines DB, Bussel JB. SARS-CoV-2 Vaccine-induced immune
thrombotic thrombocytopenia. N Engl J Med. 2021;384(23):2254-
2256.
6.Bayas A, Menacher M, Christ M, et al. Bilateral superior oph-
thalmic vein thrombosis, ischaemic stroke, and immune thrombo- cytopenia after ChAdOx1 nCoV-19 vaccination. Lancet. 2021;397(10285):e11.
7. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytope- nia: diagnosis and management update. Postgrad Med J. 2007;83(983):575-582.
8. De Michele M, Iacobucci M, Nicolini E, et al. Malignant cerebral infarction, systemic venous thrombosis and thrombocytopenia after ChAdOx1 nCov vaccination: a possible catastrophic variant of vaccine induced thrombotic thrombocytopenia. Nat Commun. 2021;12(1):4663.
9. Adam F, Kauskot A, Rosa JP, et al. Mitogen-activated protein kinas-
es in hemostasis and thrombosis. J Thromb Haemost. 2008;6(12):
2007-2016.
10. Truglia S, Mancuso S, Capozzi A, et al. "Non-criteria antiphospho-
lipid antibodies": bridging the gap between seropositive and seronegative Antiphospholipid Syndrome. Rheumatology. 2021 May 10. [Epub ahead of print]
11. Li Z, Zhang G, Feil R, et al. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activa- tion of the platelet integrin alphaIIb beta3. Blood. 2006;107(3):965- 972.
12.Capozzi A, Manganelli V, Riitano G, et al. Tissue factor over- expression in platelets of patients with anti-phospholipid syn- drome: induction role of anti-b2-GPI antibodies. Clin Exp Immunol. 2019;196(1):59-66.
13. Zhang W, Zha C, Lu X, et al. Anti-b2GPI/b2GPI complexes induce platelet activation and promote thrombosis via p38MAPK: a path- way to targeted therapies. Front Med. 2019;13(6):680-689.
14. Zohoury N, Bertolaccini ML, Rodriguez-Garcia JL, et al. Closing the serological gap in the antiphospholipid syndrome: the value of "non-criteria" antiphospholipid antibodies. J Rheumatol. 2017;44(11):1597-1602.
15.Ledford H. How could a COVID vaccine cause blood clots? Scientists race to investigate. Nature. 2021;592(7854):334-335.
haematologica | 2022; 107(1)
329